Dr. Geoffrey Funk, OPO CEO, joins Coffee & Compatibility to explain what NRP is, how it has impacted solid organ transplant allocation, and why some see it as controversial.🎉 Get 10% Off at the ASHI Store! BUT FIRST SUBSCRIBE 🎉Use code YOTL2025 at checkout to enjoy 10% off your purchase.👉 Shop Now at the ASHI Store [https://theashistore.square.site/]

Valen Keefer, a two-time transplant recipient and leading patient advocate, shares her story and insights with the Coffee & Compatibility crew.

🎉 Get 10% Off at the ASHI Store! 🎉

Use code WITTYBANTER at checkout to enjoy 10% off your purchase.

👉 Shop Now at the ASHI Store

Become an ASHI member!

https://www.ashi-hla.org/page/membership

CMS Final Rule - pg 256

https://www.cms.gov/files/document/qso-25-10-clia.pdf

HLA Director and Transfusion Medicine Specialist, Dr. Ryan Pena, joins Coffee & Compatibility to discuss how HLA laboratories can support transfusion medicine specialists. From HLA typing to anti-HLA antibody analysis in this niche service, Dr. Pena breaks it all down.

Dr. Gerald Morris, the current Chair of the OPTN Histocompatibility Committee, joins Coffee & Compatibility to discuss upcoming changes in HLA testing and nomenclature, and their potential impacts on organ allocation in the United States.

Dr. Medhat Askar joins the podcast to discuss the utility and validation of donor-derived cell-free DNA (dd-cfDNA) testing for solid-organ recipients. Dr. Askar also discusses the regulatory status of dd-cfDNA in the United States.

Dr. Christina Jorge shares what has made Portugal’s organ allocation system one of the best in the world, as well as the challenges it faces and the innovations it has planned.